Elon Musk's Neuralink is set to conduct a groundbreaking clinical study in Great Britain to test brain chips that allow patients with severe paralysis to control digital tools with their thoughts.

Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggested big pharma may finally be willing to place ...

The new drug, called YCT-529, is a first-in-class, hormone-free and orally administered male contraceptive and was developed in collaboration with Columbia University in New York and YourChoice ...

In lab mice trials, researchers found the vaccine delivery method to provide a “far superior” antibody response compared to ...

Neuralink is partnering with University College London Hospitals Trust and Newcastle Hospitals for the project, it said today ...

One laboratory at Vanderbilt Medical Center is a key part in that lengthy scientific process with the Vanderbilt Vaccine ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

In a quiet lab in Minnesota, cutting-edge science is inching closer to freeing millions of diabetics from their daily insulin routines. Dr. Melanie Graham, a pioneering researcher in transplant ...

NORTH CHICAGO, IL, USA I July 30, 2025 I AbbVie (NYSE: ABBV) today announced positive topline results from the first of two pivotal studies of the Phase 3 ...

The data shows that RORDEP-proteins boost the production of hormones like GLP-1 and PYY, which help regulate appetite and ...

A biopharmaceutical research company with ties in Andover has laid off a third of its workforce as one of the leaders in gene therapy goes through a “strategic ...